Peter Kaiser

Peter Kaiser

Company: Cleveland Clinic Lerner College of Medicine and Cole Eye Institute

Job title: Chaney Family Endowed Chair in Ophthalmology Research and Prof of Ophthalmology

Bio:

Peter K. Kaiser, M.D. is the Chaney Family Endowed Chair for Ophthalmology Research and a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine. He graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute at the Cleveland Clinic, Cleveland, Ohio. As a RO1 NIH-funded investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in AMD and diabetic retinopathy. He is director of the Cole Center for ocular Research and Evaluation (CORE). In addition, Dr Kaiser is actively involved in clinical research as Study Chairman of 7 major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, diabetic retinopathy, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR). Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, and more than 400 peer-reviewed papers. He is Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of Retina, Retina Today, and Ocular Surgery News. Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with both Achievement and Senior Achievement Awards, and is listed as one of the “Best Doctors in America.” He is the team ophthalmologist for the Cleveland Cavaliers (National Basketball Association).

Seminars:

Chair Led Q&A: Ensuring Clinical Success for the Emerging Therapeutic Approaches in the Management of Wet AMD & DME 10:00 am

How can we improve the current standard-of-care & ensure the clinical success of future clinical approaches?Read more

day: Day One

Opening Presentation: Evaluating the Unmet Clinical Need in the Angiogenesis-Driven Diseases, Neovascular/Wet Age-Related Macular Degeneration (AMD) & Diabetic Macular Edema (DME) 8:50 am

Assessing the treatment burden of existing therapies and the unmet clinical need of anti-VEGF non-responders Increasing the durability of anti-VEGF approaches Novel pharmacological approaches being investigated to improve efficacy and durability compared to the current standard-of-careRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.